Investing Profile

Ran Nussbaum

InvestorVCFounder
partner at Pontifax
Photo of Ran Nussbaum, Partner at Pontifax Venture Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
NewCo Network
1601 CONNECTIONS
Top-Patents Network
1031 CONNECTIONS
University of Washington Applied Physics Laboratory Network
837 CONNECTIONS
BlueStone Capital Partners, L.P. Network
504 CONNECTIONS
Calling Brands Network
336 CONNECTIONS
cb
$10.0M - $50.0M
$25.0M
10
CompanyStageDateRound SizeTotal Raised
Adcytherix
Series AOct 2025$120M
SeedJun 2024$32M
$160M
Co-investors: Sofia Ioannidou (Andera Partners), Ohad Hammer (Pontifax Venture Capital), Iyona Rajkomar (Dawn Biopharma)
Kamari Pharma
Series AJun 2025$23M
$23M
Co-investors: Ohad Hammer (Pontifax Venture Capital)
LB Pharmaceuticals
Series CJan 2024$75M
$75M
Co-investors: Rajul Jain (Vida Ventures, LLC)
Graviton Bioscience
Series UnknownDec 2022$40M
$40M
Fore Biotherapeutics
Series CSep 2020$57M
$250M
Co-investors: Simeon J. George (SR One), Matthew Foy (SROne), Michal Silverberg (Novartis Venture Fund), Roberto De Ponti (3B Future Health Ventures (Helsinn Investment Fund)), Chandra Leo (HBM Partners AG)
Keros Therapeutics
Series CMar 2020$56M
Series BJan 2019$23M
Series ANov 2017$11M
$90M
Co-investors: Jim Tananbaum (Foresite Capital Management)
ArQule
Post Ipo EquityNov 2017$10M
$10M
partner Calling BrandsPresent
partner BlueStone Capital Partners, L.P.Present
partner Xtripe AngelsPresent
partner University of Washington Applied Physics LaboratoryPresent
partner NewCoPresent
partner Top-PatentsPresent
partner PontifaxPresent
Sign in with Google →
Sign in with Google →